Thursday, November 20, 2008 - 7:43PM EST

Drug Therapy

1. Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma.

Author
Tas F; Derin D; Guney N; Camlica H; Aydiner A; Topuz E;
Institution
Institute of Oncology, Istanbul University, Turkey. faruktas2002@yahoo.com
Journal
Lung Cancer. 2007 Jul;57(1):79-83. Epub 2007 Mar 26.
Abstract URL
Click here to view abstract

2. Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy.

Author
Choi HJ; Cho BC; Shin SJ; Cheon SH; Jung JY; Chang J; Kim SK; Sohn JH; Kim JH;
Institution
Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seodaemun-Gu, Shinchon-Dong 134, CPO Box 8044, Seoul 120-752, South Korea.
Journal
Cancer Chemother Pharmacol. 2008 Feb;61(2):309-13. Epub 2007 Jun 19.
Abstract URL
Click here to view abstract

3. Response of asymptomatic brain metastases from small-cell lung cancer to systemic first-line chemotherapy.

Author
Seute T; Leffers P; Wilmink JT; ten Velde GP; Twijnstra A; Seute T; Leffers P; Wilmink JT; ten Velde GP; Twijnstra A;
Institution
Department of Neurology, University Hospital Maastricht, Maastricht, The Netherlands. tatseute@yahoo.co.uk
Journal
J Clin Oncol. 2006 May 1;24(13):2079-83.
Abstract URL
Click here to view abstract

4. Efficacy of two different platinum- or anthracycline-containing chemotherapy regimens for the treatment of small cell lung cancer.

Author
Tassinari, D; Genestreti, G; Pasquini, E; Papi, M; Fantini, M; Tamburini, E; Fochessati, F; Poggi, B; Imola, M; Mianulli, A M; Fattori, P P; Lazzari-Agli, L; Ioli, G; Sartori, S; Ravaioli, A;
Institution
Department of Oncology, City Hospital, viale Settembrini n. 2, 47900, Rimini, Italy. dtassinari@rimini.com
Journal
J Chemother 2005 Apr;17(2):228-36.
Abstract URL
Click here to view abstract